While the addition of tretinoin to anti-GITR did not enhance survival, there was a significant delay in tumour growth (p<0.001 against tretinoin, p=0.017 against αGITR using mixed model ANOVA) indicating some benefit of the combination treatment. Here, TNFRSF18 is linked to neoplasm.